Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short-term Investments Total Current Liabilities Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Others

CorMedix (CRMD) Non-Current Deferred Tax Liability (2025)

CorMedix has reported Non-Current Deferred Tax Liability over the past 1 years, most recently at $144.6 million for Q4 2025.

Quarterly results put Non-Current Deferred Tax Liability at $144.6 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $144.6 million (changed N/A YoY), and the annual figure for FY2025 was $144.6 million, changed.
Non-Current Deferred Tax Liability reached $144.6 million in Q4 2025 per CRMD's latest filing, roughly flat from $144.5 million in the prior quarter.
Across five years, Non-Current Deferred Tax Liability topped out at $144.6 million in Q4 2025 and bottomed at $144.5 million in Q3 2025.